J Frontier Co.,Ltd.
J Frontier Co.,Ltd. scores highest on Nitro (92) and lowest on Price (2). Its PosiPenta is 40.15 out of 100, around the middle of similar companies.
On the Penta Grid this week, J Frontier Co.,Ltd. is Grid #44 of 53 in the Healthcare sector in Japan, and Grid #877 of 1,059 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| J Frontier Co.,Ltd. | 40.15 | 2 | 48 | 92 | 13 | 45 |
| StemRIM | 28.11 | 27 | 23 | 6 | 54 | 31 |
| Morishita Jintan Co., Ltd. | 70.43 | 84 | 84 | 68 | 50 | 66 |
| Create Medic Co., Ltd. | 61.79 | 67 | 53 | 79 | 51 | 59 |
| Yamashita Health Care Holdings,Inc. | 65.52 | 64 | 87 | 70 | 50 | 57 |
| Ohki Healthcare Holdings Co.,Ltd. | 46.77 | 69 | 50 | 24 | 29 | 61 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -35.57 |
| P/B ratio | 8.79 |
EEarnings
| Trailing EPS | ₹-33.69 |
| Forward EPS | ₹43.71 |
NNitro
| Price | 1198.62 |
| 52-week high | 1268.24 |
| 52-week low | 724.02 |
| Fall from 52-week high | 5.5% |
TTorque
| Return on equity (ROE) | -14.68% |
| Debt-to-equity | 3.45 |
AAnchor
| Beta (price swings) | 0.61 |
| Market cap | ₹639 Cr |
| Insider holding | 78.39% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is J Frontier Co.,Ltd.'s PosiPenta score?
J Frontier Co.,Ltd.'s PosiPenta is 40.15 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does J Frontier Co.,Ltd. stand on the Penta Grid?
On the Penta Grid this week, J Frontier Co.,Ltd. is Grid #44 of 53 in the Healthcare sector in Japan, and Grid #877 of 1,059 in Japan.
Which PosiPenta pillar is strongest for J Frontier Co.,Ltd.?
Nitro (momentum), with a score of 92 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for J Frontier Co.,Ltd.?
Price (valuation), with a score of 2 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.